Deepak Bhatt, MD: Impact of COVID-19 on Clinical Trials in Cardiology

August 4, 2020

Deepak Bhatt, MD, offers perspective on how the ongoing pandemic has impacted clinical trials in the cardiovascular space.

This episode of the Practical Cardiology Podcast features an interview with Deepak Bhatt, MD, MPH, executive director of interventional cardiovascular programs at Brigham and Women’s Hospital and professor of medicine at Harvard Medical School, discussing clinical trials in cardiology during the ongoing pandemic.

The subject of the current interview is an article penned by Bhatt and other cardiologists addressing the impact the ongoing coronavirus disease 2019 (COVID-19) pandemic has had on cardiovascular trials in the United States, titled “The Landscape of Cardiovascular Clinical Trials in the United States Initiated Before and During COVID-19”.


A leading trialist involved in major trials including REDUCE-IT and THEMIS, Bhatt offers perspective on data from a professional and personal perspective on how the pandemic has, is, and will continue to affect clinical trials, with the ripple causing disruptions in treatment pipelines and the treatment of patients.